These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 345730)

  • 1. Doxycycline (Vibramycin) in pelvic inflammatory disease.
    Gjønnaess H; Holten E
    Acta Obstet Gynecol Scand; 1978; 57(2):137-9. PubMed ID: 345730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecundity and morbidity following acute pelvic inflammatory disease treated with doxycycline and metronidazole.
    Heinonen PK; Leinonen M
    Arch Gynecol Obstet; 2003 Oct; 268(4):284-8. PubMed ID: 14504870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amoxycillin absorption and penetration in pelvic inflammatory disease.
    Onsrud M; Gjønnaess H; Bergan T
    Acta Obstet Gynecol Scand; 1979; 58(4):401-3. PubMed ID: 525275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentration determinations and clinical effectiveness of doxycycline (Vibramycin) in the uterus, adnexa and maternal milk].
    Lutziger H
    Ther Umsch; 1969 Aug; 26(8):476-80. PubMed ID: 5355767
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating pelvic inflammatory disease with doxycycline and metronidazole or penicillin and metronidazole.
    Heinonen PK; Teisala K; Punnonen R; Aine R; Lehtinen M; Miettinen A; Paavonen J
    Genitourin Med; 1986 Aug; 62(4):235-9. PubMed ID: 3089909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of ciprofloxacin with doxycycline plus metronidazole in the treatment of acute pelvic inflammatory disease.
    Heinonen PK; Teisala K; Miettinen A; Aine R; Punnonen R; Grönroos P
    Scand J Infect Dis Suppl; 1989; 60():66-73. PubMed ID: 2756353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ceftizoxime versus combination therapy in the treatment of pelvic inflammatory disease (PID).
    Wikler MA; Moonsammy GI; Hemsell DL
    J Chemother; 1989 Jul; 1(4 Suppl):882-3. PubMed ID: 16312685
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic implications of doxycycline and cephalothin concentrations in the female genital tract.
    Whelton A; Blanco LJ; Carter GG; Craig TJ; Bryant HH; Herbst DV; King TM
    Obstet Gynecol; 1980 Jan; 55(1):28-32. PubMed ID: 7352059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of doxycycline in sepsis of gynecological and obstetric interest].
    Signorelli I
    Minerva Ginecol; 1972 Dec; 24(12):660-6. PubMed ID: 4603950
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparison of pefloxacin/metronidazole and doxycycline/metronidazole in the treatment of laparoscopically confirmed acute pelvic inflammatory disease.
    Witte EH; Peters AA; Smit IB; van der Linden MC; Mouton RP; van der Meer JW; van Erp EJ
    Eur J Obstet Gynecol Reprod Biol; 1993 Jul; 50(2):153-8. PubMed ID: 8405644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter randomized trial of ofloxacin versus cefoxitin and doxycycline in outpatient treatment of pelvic inflammatory disease. Ambulatory PID Research Group.
    Martens MG; Gordon S; Yarborough DR; Faro S; Binder D; Berkeley A
    South Med J; 1993 Jun; 86(6):604-10. PubMed ID: 8506477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxycycline in human oviduct mucosa and plasma 24-30 hours after an oral dose of 100 mg.
    Brihmer C; Brundin J
    Acta Obstet Gynecol Scand; 1985; 64(6):529-30. PubMed ID: 4061069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement in the clinical cure rate of outpatient management of pelvic inflammatory disease following a change in therapy.
    Piyadigamage A; Wilson J
    Sex Transm Infect; 2005 Jun; 81(3):233-5. PubMed ID: 15923292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of acute pelvic inflammatory disease after hysterosalpingography: efficacy of doxycycline prophylaxis.
    Pittaway DE; Winfield AC; Maxson W; Daniell J; Herbert C; Wentz AC
    Am J Obstet Gynecol; 1983 Nov; 147(6):623-6. PubMed ID: 6638106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial.
    Savaris RF; Teixeira LM; Torres TG; Edelweiss MI; Moncada J; Schachter J
    Obstet Gynecol; 2007 Jul; 110(1):53-60. PubMed ID: 17601896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion.
    Sinei SK; Schulz KF; Lamptey PR; Grimes DA; Mati JK; Rosenthal SM; Rosenberg MJ; Riara G; Njage PN; Bhullar VB
    Br J Obstet Gynaecol; 1990 May; 97(5):412-9. PubMed ID: 2196934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levels of ampicillin and doxycycline in human oviduct mucosa and serum.
    Brihmer C; Brundin J
    Acta Obstet Gynecol Scand; 1983; 62(3):231-4. PubMed ID: 6624395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment protocols for PID.
    Bainbridge CV; Rettek B
    Am Fam Physician; 1985 Aug; 32(2):47-8. PubMed ID: 4025105
    [No Abstract]   [Full Text] [Related]  

  • 19. Compliance with doxycycline therapy for outpatient treatment of pelvic inflammatory disease.
    Brookoff D
    South Med J; 1994 Nov; 87(11):1088-91. PubMed ID: 7973890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.
    Ness RB; Soper DE; Holley RL; Peipert J; Randall H; Sweet RL; Sondheimer SJ; Hendrix SL; Amortegui A; Trucco G; Songer T; Lave JR; Hillier SL; Bass DC; Kelsey SF
    Am J Obstet Gynecol; 2002 May; 186(5):929-37. PubMed ID: 12015517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.